BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 16505315)

  • 1. Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS.
    Masjuan J; Alvarez-Cermeño JC; García-Barragán N; Díaz-Sánchez M; Espiño M; Sádaba MC; González-Porqué P; Martínez San Millán J; Villar LM
    Neurology; 2006 Feb; 66(4):576-8. PubMed ID: 16505315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of CSF and MRI criteria for dissemination in space in the diagnosis of multiple sclerosis.
    Villar LM; García-Barragán N; Sádaba MC; Espiño M; Gómez-Rial J; Martínez-San Millán J; González-Porqué P; Alvarez-Cermeño JC
    J Neurol Sci; 2008 Mar; 266(1-2):34-7. PubMed ID: 17884100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased peripheral blood CD5+ B cells predict earlier conversion to MS in high-risk clinically isolated syndromes.
    Villar LM; Espiño M; Roldán E; Marín N; Costa-Frossard L; Muriel A; Alvarez-Cermeño JC
    Mult Scler; 2011 Jun; 17(6):690-4. PubMed ID: 21436320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.
    Lebrun C; Bensa C; Debouverie M; Wiertlevski S; Brassat D; de Seze J; Rumbach L; Pelletier J; Labauge P; Brochet B; Tourbah A; Clavelou P;
    Arch Neurol; 2009 Jul; 66(7):841-6. PubMed ID: 19597085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early differential diagnosis of multiple sclerosis using a new oligoclonal band test.
    Villar LM; Masjuan J; Sádaba MC; González-Porqué P; Plaza J; Bootello A; Alvarez-Cermeño JC
    Arch Neurol; 2005 Apr; 62(4):574-7. PubMed ID: 15824255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of MRI criteria for dissemination in space for the diagnosis of multiple sclerosis in patients with clinically isolated syndromes.
    Díaz-Sánchez M; Mayra Gómez-Moreno S; Asunción Morales-Otal M; Ramos-González A; Benito-León J
    Mult Scler; 2010 May; 16(5):576-80. PubMed ID: 20194582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis.
    Rovira A; Swanton J; Tintoré M; Huerga E; Barkhof F; Filippi M; Frederiksen JL; Langkilde A; Miszkiel K; Polman C; Rovaris M; Sastre-Garriga J; Miller D; Montalban X
    Arch Neurol; 2009 May; 66(5):587-92. PubMed ID: 19433658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline MRI predicts future attacks and disability in clinically isolated syndromes.
    Tintoré M; Rovira A; Río J; Nos C; Grivé E; Téllez N; Pelayo R; Comabella M; Sastre-Garriga J; Montalban X
    Neurology; 2006 Sep; 67(6):968-72. PubMed ID: 17000962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?
    Tintoré M; Rovira A; Río J; Tur C; Pelayo R; Nos C; Téllez N; Perkal H; Comabella M; Sastre-Garriga J; Montalban X
    Neurology; 2008 Mar; 70(13 Pt 2):1079-83. PubMed ID: 17881717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS.
    Tintoré M; Rovira A; Brieva L; Grivé E; Jardí R; Borrás C; Montalban X
    Mult Scler; 2001 Dec; 7(6):359-63. PubMed ID: 11795456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal cord lesions in patients with clinically isolated syndrome: a powerful tool in diagnosis and prognosis.
    Sombekke MH; Wattjes MP; Balk LJ; Nielsen JM; Vrenken H; Uitdehaag BM; Polman CH; Barkhof F
    Neurology; 2013 Jan; 80(1):69-75. PubMed ID: 23243070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of cerebrospinal fluid oligoclonal bands to the early diagnosis of multiple sclerosis.
    Zipoli V; Hakiki B; Portaccio E; Lolli F; Siracusa G; Giannini M; Pantoni L; Pescini F; Sorbi S; Amato MP
    Mult Scler; 2009 Apr; 15(4):472-8. PubMed ID: 19153171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical isolated syndrome: a 3-year follow-up study in China.
    Liu Y; Duan Y; Yu C; Qin W; Chen H; Dong H; Ye J; Butzkueven H; Li K
    Clin Neurol Neurosurg; 2011 Oct; 113(8):658-60. PubMed ID: 21680087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors after a first attack of inflammatory CNS demyelination in children.
    Neuteboom RF; Boon M; Catsman Berrevoets CE; Vles JS; Gooskens RH; Stroink H; Vermeulen RJ; Rotteveel JJ; Ketelslegers IA; Peeters E; Poll-The BT; De Rijk-Van Andel JF; Verrips A; Hintzen RQ
    Neurology; 2008 Sep; 71(13):967-73. PubMed ID: 18672475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Callosal lesion predicts future attacks after clinically isolated syndrome.
    Jafari N; Kreft KL; Flach HZ; Janssens AC; Hintzen RQ
    Neurology; 2009 Dec; 73(22):1837-41. PubMed ID: 19949029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease.
    Siva A; Saip S; Altintas A; Jacob A; Keegan BM; Kantarci OH
    Mult Scler; 2009 Aug; 15(8):918-27. PubMed ID: 19667020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Spanish cohort of patients with clinically isolated syndromes.
    Gómez-Moreno M; Díaz-Sánchez M; Ramos-González A
    Mult Scler; 2012 Jan; 18(1):39-44. PubMed ID: 21865413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of oligoclonal IgG band detection for MS diagnosis in daily clinical practice.
    Abraira V; Alvarez-Cermeño JC; Arroyo R; Cámara C; Casanova B; Cubillo S; de Andrés C; Espejo C; Fernández O; Ferrer J; Figueredo MA; García-Merino A; García-Sánchez MI; García-Trujillo JA; Gómez M; González-Oria C; Gosis A; Izquierdo G; Jímenez J; López-Trascasa M; Montalbán X; Moreno MJ; Muñoz D; Nuñez V; Muriel A; Navarro J; Olascoaga J; Oreja-Guevara C; Prada A; Ramil E; Ramo-Tello C; Rodríguez C; Rodríguez E; Rodríguez-Frías F; Rodríguez-Antigüedad A; Rodríguez-Molina JJ; Ruiz E; Saiz A; Sarasola E; Simó M; Yagüe J; Villar LM
    J Immunol Methods; 2011 Aug; 371(1-2):170-3. PubMed ID: 21704629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta1a.
    Barkhof F; Rocca M; Francis G; Van Waesberghe JH; Uitdehaag BM; Hommes OR; Hartung HP; Durelli L; Edan G; Fernández O; Seeldrayers P; Sørensen P; Margrie S; Rovaris M; Comi G; Filippi M;
    Ann Neurol; 2003 Jun; 53(6):718-24. PubMed ID: 12783417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Demyelinating lesions as incidental findings in magnetic resonance imaging: a study of 11 cases with clinico-radiological follow-up and a review of the literature].
    Sierra-Marcos A; Mitjana R; Castilló J; Edo MC; Horga-Hernández A; Tintoré M; Río-Izquierdo J; Auger-Acosta C; Rovira A; Montalban X
    Rev Neurol; 2010 Aug; 51(3):129-34. PubMed ID: 20645263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.